semaglutide approval date The upcoming expiry of the patent in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Novo Nordisk's Wegovy Weight-Loss Drug
Description
Retinal vein occlusion (blockage in the blood vessels that carry blood out of the eye)
The average trial length for Overweight is 12 months
Regulators require strong evidence that the molecule being developed is exactly what it is claimed to be
Check blood ketones if you have persistent vomiting or blood glucose above 11 mmol/L, particularly during illness
Understanding what evidence actually exists versus what marketing claims suggest proves essential
It also slows down the digestive process so that any food youve eaten stays in your stomach for longer, making you feel more satisfied
